COVID-19

Ken Thai, PharmD, Drug Topics editorial advisory board member, lists the key trends from 2020 and where he envisions pharmacy going in 2021.

Lakesha Butler, PharmD, Drug Topics editorial advisory board member, examines 2020 trends in diversity, equity and inclusion within health care and explores the year ahead.

Cody Clifton, PharmD, CPESN USA, discusses the organization's pharmacy integration network and the pharmacists' role amid the coronavirus pandemic.

The Drug Topics® team rounded up some of our top-read articles from the last year.

Here’s the last roundup of the latest coronavirus-related news in 2020.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event on the disproportionate impact of COVID-19 among racial and ethnic minority groups.

Our latest podcast episode discusses how pharmacies can tap technology to boost vaccination programs for COVID-19 vaccines and others.

The FDA has authorized the Moderna mRNA vaccine for emergency use, making it the second vaccine for COVID-19.

Here’s a roundup of the latest coronavirus-related news.

US health care workers have started receiving the COVID-19 vaccine, but we are still months away from approving the vaccine for use in children, according to Fauci.

This week, members of the MJH Life Sciences COVID-19 Coalition shared insights on the latest pandemic news, including long-term health consequences, vaccine hesitancy, and new recommendations.

In a session held during ASHP Midyear 2020 Clinical Meeting & Exhibition, Anthony Fauci, MD, warned pharmacists of challenging months ahead amid the COVID-19 pandemic.

The FDA has granted emergency use authorization (EUA) to the Pfizer/BioNTech COVID-19 vaccine.

Here’s a roundup of the latest coronavirus-related news:

The FDA is not required to follow the committee's advice, but it is expected to do so.

Pharmacists can prepare themselves to address patients’ questions and concerns about the COVID-19 vaccines.

Here’s a roundup of the latest coronavirus-related news.

Pharmacists may be among the first of the prioritized groups to be offered the COVID-19 vaccine once it receives FDA authorization.

CVS Health will pilot the administration of a limited supply of the monoclonal antibody therapy bamlanivimab to eligible patients at home or in long-term care facilities.

A survey conducted by the American Pharmacists Association asked pharmacists if they were ready to receive and administer COVID-19 vaccines.

The first doses of the mRNA COVID-19 vaccine will be delivered in the UK in the next few days, Pfizer announced.

Moderna reported an efficacy rate of 94.1% for its COVID-19 vaccine based on the primary efficacy analysis.

A recent study showed “alarming” rates of reported loneliness, anxiety, depression, and substance use in young adults during COVID-19.

Here’s a roundup of this week’s coronavirus-related news.

A study to be presented at the annual meeting of the Radiological Society of North America reported that COVID-19 patients with diabetes and hypertension may have a higher risk for neurologic complications.